Major shareholder announcement

Baillie Gifford & Co has increased its holding of B shares in Novozymes A/S to 7.81% of Novozymes A/S’ share capital and 3.14% of the voting rights.

In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co (through holdings in Baillie Gifford & Co, and through its wholly owned subsidiary, Baillie Gifford Overseas Limited) has increased its holding of B shares in Novozymes A/S to a total of 25,388,300 B shares of a nominal value of DKK 50,776,600, equivalent to 7.81% of Novozymes A/S’ share capital and 3.14% of the voting rights.